| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Travere Therapeutics, Inc. | Director | Common Stock | 30K | $550K | $18.33 | 15 May 2025 | Direct |
| Travere Therapeutics, Inc. | Director | Stock option (right to buy) | 19.5K | 15 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | 15 May 2025 | 2 | $0 | 4 | Director | 16 May 2025, 19:00 |
| TVTX | Travere Therapeutics, Inc. | 08 May 2024 | 2 | $0 | 4 | Director | 10 May 2024, 16:05 |
| TVTX | Travere Therapeutics, Inc. | 17 May 2023 | 2 | $0 | 4 | Director | 19 May 2023, 16:06 |
| TVTX | Travere Therapeutics, Inc. | 11 May 2022 | 2 | $0 | 4 | Director | 12 May 2022, 20:33 |
| TVTX | Travere Therapeutics, Inc. | 14 May 2021 | 2 | $0 | 4 | Director | 18 May 2021, 21:13 |